About Us
Trusted Advisors in UK Medical Cannabis Healthcare
Montespada Consultancy helps organisations navigate the complex regulatory landscape of UK medical cannabis. We partner with clinics and healthcare services to build safe, compliant, regulatory‑ready operations grounded in governance, structured clinical pathways and practical operational frameworks.
We understand that medical cannabis is a highly regulated area of healthcare requiring precision, clarity and robust systems — not generic advice or off‑the‑shelf solutions. Our work focuses on designing sustainable governance, preparing services for CQC registration, and helping teams embed clear processes, policies and communications that support safe prescribing and consistent patient experience.
Services include regulatory insight and compliance support, governance frameworks, clinical and patient pathway development, documentation and communication optimisation, and tailored training for clinical and administrative teams.
We work collaboratively and discreetly with senior teams, combining sector‑specific expertise with structured planning to help organisations operate with confidence and clarity in this specialised field.
Meet the Team
A specialist team with deep experience in medical cannabis regulation, strategy, and delivery.
Amber Spadone-Beaumont
Consultant – Governance & Compliance
Amber Spadone‑Beaumont supports UK medical cannabis clinics with governance development, clinical pathway design, regulatory readiness and operational structure.
She works with new and established services to build clear, compliant operating models that support safe prescribing, consistent patient journeys and confident leadership.
Her work focuses on translating regulatory and governance requirements into practical, workable systems that fit real‑world clinic operations. Amber supports clinics through setup, CQC registration and ongoing compliance, helping services operate with clarity, structure and confidence.
Alongside her consultancy work, Amber serves as the Operations Director of the Medical Cannabis Clinicians Society, a separate professional body that supports clinicians working in the UK medical cannabis sector. This role sits independently of the consultancy.
Benjamin Beaumont
Consultant – Design, Digital & Communications
Benjamin leads the design-led and digital aspects of the consultancy’s work, supporting medical cannabis clinics with website builds, content structure, documentation design, and clear, compliant communication. His focus is on translating governance, pathways and regulatory requirements into accessible, well‑designed materials that support both patient understanding and operational clarity.
He works closely on website builds, website content and compliance review, documentation customisation and branding, and communication and messaging support, ensuring that public‑facing and internal materials are clear, consistent and aligned with clinic operations.
Alongside this, Benjamin contributes across wider consultancy projects, working collaboratively on governance, pathways and compliance to ensure that design and communication work accurately reflects how clinics function in practice.
Professor Mike Barnes
Advisor & Training Contributor
Professor Mike Barnes supports the consultancy in an advisory capacity and contributes to the development and delivery of selected training. His role is to support the consultancy team and its work, rather than to provide services directly to individual clinics.
Professor Barnes brings extensive experience in neurology, neurorehabilitation and medical cannabis, and has played a significant role in the development of clinical understanding and professional education within the UK medical cannabis sector. His contribution focuses on supporting high‑quality training content and strengthening clinical insight within the consultancy’s services.
Training is delivered as part of the consultancy’s structured programmes and remains coordinated and led by the consultancy. Professor Barnes is not involved in the operational management of the business and does not provide direct clinical, regulatory or advisory services to clinics.